Subscribe To
Top- and bottom-line beat gives regeneron stock a boost
Regeneron pharmaceuticals Inc (NASDAQ:REGN) is up 1.9% to trade at $632.42 at last check, after the dr...
February 4, 2022, 10:26 am
Bristol-myers q4 results are out: this is what the report tells us
Shares of Bristol-Myers Squibb Co (NYSE: BMY) jumped 3.0% on Friday morning after the pharmaceutical gi...
February 4, 2022, 10:08 am
Bristol-myers q4 results are out: this is what the report tells us
Shares of Bristol-Myers Squibb Co (NYSE: BMY) jumped 3.0% on Friday morning after the pharmaceutical gi...
February 4, 2022, 10:08 am
Bristol-myers q4 results are out: this is what the report tells us
Shares of Bristol-Myers Squibb Co (NYSE: BMY) jumped 3.0% on Friday morning after the pharmaceutical gi...
February 4, 2022, 10:08 am
Why are vanda pharma shares plunging today?
Vanda pharmaceuticals Inc VNDA shares are plunging after the company announced Phase 3 trial data of ...
February 4, 2022, 8:34 am
Why are vanda pharma shares plunging today?
Vanda pharmaceuticals Inc VNDA shares are plunging after the company announced Phase 3 trial data of ...
February 4, 2022, 8:34 am
Why are vanda pharma shares plunging today?
Vanda pharmaceuticals Inc VNDA shares are plunging after the company announced Phase 3 trial data of ...
February 4, 2022, 8:34 am
Regeneron's q4 sales, profits more than double with boost from covid-19 treatment sales
Regeneron pharmaceuticals Inc REGN earned $23.72 per share for Q4 FY21, more than double from $9.53 ...
February 4, 2022, 8:01 am
Regeneron's q4 sales, profits more than double with boost from covid-19 treatment sales
Regeneron pharmaceuticals Inc REGN earned $23.72 per share for Q4 FY21, more than double from $9.53 ...
February 4, 2022, 8:01 am
Regeneron's q4 sales, profits more than double with boost from covid-19 treatment sales
Regeneron pharmaceuticals Inc REGN earned $23.72 per share for Q4 FY21, more than double from $9.53 ...
February 4, 2022, 8:01 am
Algernon pharmaceuticals completes enrollment in its phase 2 study of ifenprodil for ipf and chronic cough
Algernon pharmaceuticals Inc said it has completed enrollment in a Phase 2 study for its repurposed dru...
February 4, 2022, 7:57 am
Algernon pharmaceuticals completes enrollment in its phase 2 study of ifenprodil for ipf and chronic cough
Algernon pharmaceuticals Inc said it has completed enrollment in a Phase 2 study for its repurposed dru...
February 4, 2022, 7:57 am
Algernon pharmaceuticals completes enrollment in its phase 2 study of ifenprodil for ipf and chronic cough
Algernon pharmaceuticals Inc said it has completed enrollment in a Phase 2 study for its repurposed dru...
February 4, 2022, 7:57 am
Nyse-listed pharma co. dr. reddy's to acquire german medical cannabis firm nimbus health gmbh
pharmaceutical company Dr. Reddy's Laboratories Ltd. RDY has entered into a definitive agreement to acq...
February 4, 2022, 7:37 am
Nyse-listed pharma co. dr. reddy's to acquire german medical cannabis firm nimbus health gmbh
pharmaceutical company Dr. Reddy's Laboratories Ltd. RDY has entered into a definitive agreement to acq...
February 4, 2022, 7:37 am
Nyse-listed pharma co. dr. reddy's to acquire german medical cannabis firm nimbus health gmbh
pharmaceutical company Dr. Reddy's Laboratories Ltd. RDY has entered into a definitive agreement to acq...
February 4, 2022, 7:37 am
Regeneron shares up premarket after q4 revenue doubles and blows past estimates
Regeneron pharmaceuticals Inc. shares REGN, -0.35% rose 1.8% in premarket trade Friday, after the compa...
February 4, 2022, 6:41 am
Regeneron shares up premarket after q4 revenue doubles and blows past estimates
Regeneron pharmaceuticals Inc. shares REGN, -0.35% rose 1.8% in premarket trade Friday, after the compa...
February 4, 2022, 6:41 am
Regeneron shares up premarket after q4 revenue doubles and blows past estimates
Regeneron pharmaceuticals Inc. shares REGN, -0.35% rose 1.8% in premarket trade Friday, after the compa...
February 4, 2022, 6:41 am
Regeneron quarterly profit nearly doubles on robust sales of covid-19 therapy
Regeneron pharmaceuticals quarterly profit nearly doubled on Thursday, on strong sales of its COVID-19 ...
February 4, 2022, 6:38 am